↓ Skip to main content

Dove Medical Press

Article Metrics

Maintenance erlotinib in advanced nonsmall cell lung cancer: cost-effectiveness in EGFR wild-type across Europe

Overview of attention for article published in ClinicoEconomics and Outcomes Research: CEOR, September 2012
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (64th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

policy
1 policy source

Citations

dimensions_citation
18 Dimensions

Readers on

mendeley
37 Mendeley
Title
Maintenance erlotinib in advanced nonsmall cell lung cancer: cost-effectiveness in EGFR wild-type across Europe
Published in
ClinicoEconomics and Outcomes Research: CEOR, September 2012
DOI 10.2147/ceor.s31794
Pubmed ID
Authors

Hubertus Rosery, Walleser, Ray, Bischoff, alain vergnenegre, Hubertus Rosery, Christos Chouaid, David Heigener, de Castro, Marcello Tiseo, Stefan Walzer

Mendeley readers

The data shown below were compiled from readership statistics for 37 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 37 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 5 14%
Other 3 8%
Student > Master 3 8%
Professor 1 3%
Student > Ph. D. Student 1 3%
Other 3 8%
Unknown 21 57%
Readers by discipline Count As %
Medicine and Dentistry 7 19%
Agricultural and Biological Sciences 2 5%
Business, Management and Accounting 2 5%
Pharmacology, Toxicology and Pharmaceutical Science 2 5%
Economics, Econometrics and Finance 2 5%
Other 1 3%
Unknown 21 57%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 June 2018.
All research outputs
#3,845,956
of 13,040,510 outputs
Outputs from ClinicoEconomics and Outcomes Research: CEOR
#115
of 350 outputs
Outputs of similar age
#115,917
of 343,679 outputs
Outputs of similar age from ClinicoEconomics and Outcomes Research: CEOR
#6
of 16 outputs
Altmetric has tracked 13,040,510 research outputs across all sources so far. This one is in the 49th percentile – i.e., 49% of other outputs scored the same or lower than it.
So far Altmetric has tracked 350 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.9. This one has gotten more attention than average, scoring higher than 62% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 343,679 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.
We're also able to compare this research output to 16 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.